BPC-157 is a synthetic pentadecapeptide, meaning a chain of fifteen amino acids, derived from a naturally occurring protein in human gastric juice called Body Protection Compound
For localized injuries like adductor strains, however, injectable BPC-157 remains the preferred delivery method because it allows for targeted administration near the damaged tissue
FDA requires precise characterization of drug productsdifficult for complex peptide mixtures derived from animal tissue
The reasons cited by the FDA included concerns about immunogenicity, peptide impurity characterization challenges, and the lack of adequate safety data from human clinical trials
Peptide Components Each peptide in KLOW targets distinct cellular signaling pathways and contributes to a broader research framework focused on tissue response, cellular communication, and physiological regulation